| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjunctive anticoagulation during peripheral vascular intervention
|
Donovan, Robert J.
|
|
2016
|
172 |
C |
p. 106-114
9 p.
|
article
|
| 2 |
Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial
|
Liu, Yong
|
|
2016
|
172 |
C |
p. 88-95
8 p.
|
article
|
| 3 |
Automatic external defibrillator–only resuscitation in cardiac arrest? The approach may be shocking!
|
Olshansky, Brian
|
|
2016
|
172 |
C |
p. 182-184
3 p.
|
article
|
| 4 |
Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables
|
Didier, Romain
|
|
2016
|
172 |
C |
p. 80-87
8 p.
|
article
|
| 5 |
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients
|
Capucci, Alessandro
|
|
2016
|
172 |
C |
p. 192-200
9 p.
|
article
|
| 6 |
Computer-guided normal-low versus normal-high potassium control after cardiac surgery: No impact on atrial fibrillation or atrial flutter
|
Hoekstra, Miriam
|
|
2016
|
172 |
C |
p. 45-52
8 p.
|
article
|
| 7 |
Corrigendum to “Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)” (Am Heart J. 2015;170[4]:627-634)
|
Dokainish, Hisham
|
|
2016
|
172 |
C |
p. 201-
1 p.
|
article
|
| 8 |
Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia
|
Nytrøen, Kari
|
|
2016
|
172 |
C |
p. 96-105
10 p.
|
article
|
| 9 |
Editorial Board
|
|
|
2016
|
172 |
C |
p. A4-
1 p.
|
article
|
| 10 |
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial
|
Eisen, Alon
|
|
2016
|
172 |
C |
p. 144-151
8 p.
|
article
|
| 11 |
Employment and residential characteristics in relation to automated external defibrillator locations
|
Griffis, Heather M.
|
|
2016
|
172 |
C |
p. 185-191
7 p.
|
article
|
| 12 |
Evaluation of a provocative dyspnea severity score in acute heart failure
|
AbouEzzeddine, Omar F.
|
|
2016
|
172 |
C |
p. 34-41
8 p.
|
article
|
| 13 |
Excess weight and life expectancy after acute myocardial infarction: The obesity paradox reexamined
|
Bucholz, Emily M.
|
|
2016
|
172 |
C |
p. 173-181
9 p.
|
article
|
| 14 |
Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS): Rationale and design of a prospective randomized multicenter study
|
Haeusler, Karl Georg
|
|
2016
|
172 |
C |
p. 19-25
7 p.
|
article
|
| 15 |
Information for Readers
|
|
|
2016
|
172 |
C |
p. A5-
1 p.
|
article
|
| 16 |
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial
|
Thiele, Holger
|
|
2016
|
172 |
C |
p. 160-169
10 p.
|
article
|
| 17 |
Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction
|
Wang, Tracy Y.
|
|
2016
|
172 |
C |
p. 9-18
10 p.
|
article
|
| 18 |
Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)
|
Dasari, Tarun W.
|
|
2016
|
172 |
C |
p. 1-8
8 p.
|
article
|
| 19 |
Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease
|
Saiki, Hirofumi
|
|
2016
|
172 |
C |
p. 152-159
8 p.
|
article
|
| 20 |
Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel
|
Wang, Andrew
|
|
2016
|
172 |
C |
p. 70-79
10 p.
|
article
|
| 21 |
Reducing cardiovascular risk through treatment of obstructive sleep apnea: 2 methodological approaches
|
Yaggi, Henry Klar
|
|
2016
|
172 |
C |
p. 135-143
9 p.
|
article
|
| 22 |
Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?
|
Pesaro, Antonio Eduardo P.
|
|
2016
|
172 |
C |
p. 42-44
3 p.
|
article
|
| 23 |
Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute–Bristol-Myers Squibb Supporting Open Access to Researchers Initiative
|
Pencina, Michael J.
|
|
2016
|
172 |
C |
p. 64-69
6 p.
|
article
|
| 24 |
Table of Contents
|
|
|
2016
|
172 |
C |
p. A1-A3
nvt p.
|
article
|
| 25 |
The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
|
Sebben, Juliana C.
|
|
2016
|
172 |
C |
p. 26-33
8 p.
|
article
|
| 26 |
Thrombus aspiration in patients with large anterior myocardial infarction
|
Calais, Fredrik
|
|
2016
|
172 |
C |
p. 129-134
6 p.
|
article
|
| 27 |
Trends in hospitalization for takotsubo cardiomyopathy in the United States
|
Khera, Rohan
|
|
2016
|
172 |
C |
p. 53-63
11 p.
|
article
|
| 28 |
Untangling the paradox: Obesity as prognostic marker in prevalent cardiovascular disease
|
O'Brien, Emily C.
|
|
2016
|
172 |
C |
p. 170-172
3 p.
|
article
|
| 29 |
Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis
|
Sara, Jaskanwal D.S.
|
|
2016
|
172 |
C |
p. 115-128
14 p.
|
article
|
Journal description